FEATURED VIDEOS

Editor's choice

Abd Tahrani, Chantal Mathieu and Rayaz Malik discuss their experiences with the European Endocrinology journal and the touchENDOCRINOLOGY digital platform, and why it's a key part of their ongoing education. Highlights include how the open-access reviews and videos are perfect...

Latest Videos

As well as our peer-reviewed journals, we also provide video interviews, procedures and general updates on the latest trends within the area, as well as featuring carefully selected video from our partners.

ENDOCRINOLOGY INSIGHTS

The following are quick, non peer-reviewed, opinion-based updates addressing current trends and opinion on the most recent advances in the area of endocrinology:

Insight
Lipodystrophy – an Insight into a Rare Condition with Severe Metabolic Consequences Katrina Mountfort, Senior Medical Writer, Touch Medical Media, UK
Matthew Goodwin, Group Director and Advisory Editor, Touch Medical Media, UK
-Insights into lipodystrophies, presented at the European Congress of Endocrinology (ECE), Barcelona, Spain on Monday 21 May 2018
Insight
How Weight is Lost Following Bariatric Surgery Affects the Reversal of Type 2 Diabetes Stefan Amisten, Senior Medical Writer, Touch Medical Media, UK
Jeremy Betts, Advisory Editor, Touch Medical Media, UK
-Insights into STAMPEDE clinical trial from the Cleveland Clinic, presented at AACE, Boston, US, on 16–20 May, 2018
Insight
New Tool to Assess Bone Health in Patients with Obesity Katrina Mountfort, Senior Medical Writer, Touch Medical Media, Reading, UK
Matthew B Goodwin, Group Director and Advisory Editor, Touch Medical Media, Reading, UK
-Insights into the BMD/BMI tool for assessing bone health, presented at AACE, Boston, MA, US, on 16–20 May 2018
Insight
Cardiovascular outcome trials: results of CANVAS and analysis of LEADER presented at ADA 2017 Sayed Mia, Endocrinology Account Director, Touch Medical Media, UK
Katrina Mountfort, Senior Medical Writer, Touch Medical Media, UK
-Insights into recent CVOTs, discussed at the ADA, 77th Scientific Sessions, San Diego, CA, June 11th 2017
Insight
Insulin degludec – latest study findings show cardiovascular safety as well as significant reductions in hypoglycemia and HbA1c in people with types 1 and 2 diabetes Matthew Goodwin, Endocrinology Business Unit Director, Touch Medical Media, UK
Katrina Mountfort, Senior Medical Writer, Touch Medical Media, UK
-Insights into the CV Safety of Insulin Degludec, discussed at the ADA, 77th Scientific Sessions, San Diego, CA, June 11th 2017